Skip to content
Rio de Janeiro · São Paulo · Salvador — matters across Brazil
Bruno Marcelos — Escritório de Advocacia

Pauta Regulatória · Daily brief

No. 13

· covers 17 and 20/10/2025

Automatically translated from the Portuguese edition, which prevails in case of discrepancy. Ler em português

Federal Official Gazette

No updates.

ANS news

No updates.

Open public consultations

  • CP 162. Aims to receive input on the proposed updates to the List of Health Procedures and Events (Rol). Deadline: Oct 9, 2025 to Oct 28, 2025.

Scheduled public hearings

  • AP 60. Aims to collect input on the preliminary recommendation against incorporation for the following technology: (i) UAT 172 – Risankizumab for the treatment of adult patients with moderately to severely active ulcerative colitis or ulcerative proctocolitis after failure, refractoriness, relapse or intolerance to anti-TNF therapy. Date: Oct 17, 2025, from 9:30 a.m. to 11 a.m.

Open public calls for input

There is no open public call for input.

Open public calls

No updates.

Other news

Provisions grow and may lead to larger price adjustments for health plans

Source: valor.globo.com · read the full article

Small businesses may enter into family health plan contracts

Source: conjur.com.br · read the full article

Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.